Psy185 - Alternative Methodologies Implemented by Hta Agencies for Orphan Drugs: A Scoping Review

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2759
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Reimbursement Decision Landscape for Orphan Drugs Across Six Hta Agencies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Hta Studies on Orphan Drugs by Rebratsxmembers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Are Orphan Drugs Treated the Same Across Europe: An Hta Case Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Comparison of Recent Hta Appraisals of Orphan Drugs by Nice, SMC and Has in 2015-2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Bridging HTA Agencies Across Europe: A Systematic Approach to Categorize Evolving Agencies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Psy180 - Uk Health Technology Assessment of Orphan Drugs for Rare Oncology Versus Rare Disease: Does Orphan Designation Make Any Difference in Hta Process?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php277 - How Do Bellwether Hta Agencies Evaluate Biosimilars?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn64 - Review of Nice Hta Submissions Including Methodologies Adjusting for Overall Survival in the Presence of Treatment Switching

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy